ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

GRDN vs YI // EV/EBITDA & P/E VALUATION

Guardian Pharmacy Services Inc. (Class A) (NYSE) VS. 111 Inc. (NASDAQ) • 15-METRIC TALLY: GRDN 8 — YI 0
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GRDN VS. YI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC GRDN YI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 20.20% 5.80% +14.40 GRDN /gross-margins <GO>
Return on Invested Capital (ROIC) 37.70% -20.50% +58.20 GRDN /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 34.3x — — TIE /valuation <GO>
Free Cash Flow Yield 3.91% — — TIE /fcf-yield <GO>
Operating Margin 5.00% 0.00% +5.00 GRDN /operating-margins <GO>
Net Profit Margin 3.40% — — TIE /net-margins <GO>
Revenue Growth (YoY) 17.90% -9.00% +26.90 GRDN /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 12.39 3.34 +9.05 GRDN /balance-sheet <GO>
Piotroski F-Score Quality 7/9 3/9 +4.00 GRDN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 50.6 32.8 +17.74 GRDN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 43.8x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.56B $26.2M $2.54B GRDN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR GRDN REV YI REV GRDN GROSS % YI GROSS % GRDN FCF YI FCF
FY 2025 $1.45B $1.80B 20.2% 5.8% $100.3M $16.4M
FY 2024 $1.23B $1.97B 19.9% 5.8% $58.0M $34.0M
FY 2023 — $2.11B — — — -$63.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GRDN // BETA —
YI // BETA —